View Older Stories View More Recent Stories

Apr 30, 2025 02:00AM PureTech Announces Annual Results for Year Ended December 31, 2024
Apr 23, 2025 02:00AM PureTech Health: Notice of Results
Apr 9, 2025 02:00AM PureTech Appoints Peel Hunt as Joint UK Corporate Broker
Mar 11, 2025 07:06AM PureTech Health Plc (PRTC) Appoints Robert J. Hombach to its Board
Mar 11, 2025 07:05AM PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
Feb 25, 2025 07:27AM PureTech to Present at the Leerink Partners Global Healthcare Conference
Feb 12, 2025 07:05AM PureTech (PRTC) Founded Entity Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with Glyp
Feb 12, 2025 07:05AM PureTech Founded Entity Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with GlyphTM Pla
Jan 27, 2025 02:00AM PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
Jan 9, 2025 07:00AM PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)
Jan 8, 2025 07:00AM PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference
Jan 6, 2025 02:00AM PureTech Appoints UBS as UK Corporate Broker
Dec 16, 2024 02:00AM PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondar
Dec 11, 2024 07:05AM PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Dec 9, 2024 02:00AM PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting
Nov 20, 2024 07:05AM PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
Nov 5, 2024 07:05AM PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
Oct 30, 2024 07:00AM PureTech to Present at Two Upcoming Investor Conferences
Oct 21, 2024 02:00AM PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
Oct 9, 2024 02:00AM PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
Oct 1, 2024 07:00AM PureTech to Present at CHEST 2024 Annual Meeting
Sep 27, 2024 06:54AM PureTech Health Plc (PRTC) -Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
Sep 27, 2024 02:00AM PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
Sep 6, 2024 02:00AM PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
Aug 28, 2024 02:01AM PureTech Health plc – Half-Year Report
Aug 22, 2024 02:00AM PureTech Appoints Michele Holcomb, PhD, to Board of Directors
Aug 21, 2024 02:00AM PureTech Health: Notice of Half-Yearly Results
Aug 13, 2024 07:06AM PureTech Health-founded (PRTC) Seaport Therapeutics Appoints David Wheadon to its Board
Aug 13, 2024 07:05AM PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors
Jul 23, 2024 08:26AM PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial
Jun 24, 2024 12:00PM PureTech Health: Completion of Tender Offer & Total Voting Rights
Jun 24, 2024 02:00AM PureTech Health: Results of the Tender Offer
Jun 20, 2024 05:45AM PureTech Health Plc (PRTC) Appoints Raju Kucherlapati as Board Chair
Jun 20, 2024 02:00AM PureTech Announces Change of Board Role
Jun 18, 2024 07:06AM PureTech Health Plc (PRTC) Founded Entity Seaport Therapeutics Appoints Management Executives
Jun 18, 2024 07:05AM PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team
Jun 13, 2024 01:15PM PureTech Health: Results of Annual General Meeting
Jun 6, 2024 12:38PM PureTech Health: Result of General Meeting
May 29, 2024 08:09AM PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
May 23, 2024 07:00AM PureTech to Present at the Jefferies Global Healthcare Conference
May 21, 2024 07:05AM PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
May 20, 2024 02:00AM PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
May 9, 2024 07:05AM PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
May 7, 2024 07:05AM PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
Apr 25, 2024 05:22AM PureTech Announces Annual Results for Year Ended December 31, 2023
Apr 18, 2024 02:00AM PureTech Health: Notice of Results
Apr 16, 2024 07:00AM PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
Apr 11, 2024 07:00AM PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
Apr 9, 2024 02:00AM PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
Mar 19, 2024 04:14AM PureTech Health Plc (PRTC) Announces Proposed $100M Capital Return
View More Recent Stories View Older Stories